BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33051485)

  • 1. Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours.
    Bártů M; Hojný J; Hájková N; Michálková R; Krkavcová E; Hadravský L; Kleissnerová L; Bui QH; Stružinská I; Němejcová K; Čapoun O; Šlemendová M; Dundr P
    Sci Rep; 2020 Oct; 10(1):17151. PubMed ID: 33051485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, Epigenetic, and Genetic Changes of HNF1B in Colorectal Lesions: an Analysis of 145 Cases.
    Bártů M; Hojný J; Hájková N; Michálková R; Krkavcová E; Simon K; Frýba V; Stružinská I; Němejcová K; Dundr P
    Pathol Oncol Res; 2020 Oct; 26(4):2337-2350. PubMed ID: 32488808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions.
    Němejcová K; Tichá I; Kleiblová P; Bártů M; Cibula D; Jirsová K; Dundr P
    Pathol Oncol Res; 2016 Jul; 22(3):523-30. PubMed ID: 26685938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.
    Sun M; Tong P; Kong W; Dong B; Huang Y; Park IY; Zhou L; Liu XD; Ding Z; Zhang X; Bai S; German P; Powell R; Wang Q; Tong X; Tannir NM; Matin SF; Rathmell WK; Fuller GN; McCutcheon IE; Walker CL; Wang J; Jonasch E
    Cancer Res; 2017 Oct; 77(19):5313-5326. PubMed ID: 28807937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.
    Cuff J; Salari K; Clarke N; Esheba GE; Forster AD; Huang S; West RB; Higgins JP; Longacre TA; Pollack JR
    PLoS One; 2013; 8(9):e74562. PubMed ID: 24040285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
    Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
    Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.
    Wang CC; Mao TL; Yang WC; Jeng YM
    Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of papillary renal cell tumours identifies small regions of DNA alterations: a possible role of HNF1B in tumour development.
    Szponar A; Yusenko MV; Kuiper R; van Kessel AG; Kovacs G
    Histopathology; 2011 May; 58(6):934-43. PubMed ID: 21438902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal failure of unknown origin is caused by HNF1B mutations in 9% of adult patients: a single centre cohort analysis.
    Musetti C; Quaglia M; Mellone S; Pagani A; Fusco I; Monzani A; Giordano M; Stratta P
    Nephrology (Carlton); 2014 Apr; 19(4):202-9. PubMed ID: 24387224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation of the HNF1B gene associated with hypoplastic glomerulocystic kidney disease and neonatal renal failure: a case report and mutation update.
    Alvelos MI; Rodrigues M; Lobo L; Medeira A; Sousa AB; Simão C; Lemos MC
    Medicine (Baltimore); 2015 Feb; 94(7):e469. PubMed ID: 25700310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
    Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
    Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics].
    Brauch H; Böhm J; Höfler H
    Pathologe; 1995 Sep; 16(5):321-7. PubMed ID: 7479604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for HNF1B analysis in patients with congenital abnormalities of kidney and urinary tract.
    Raaijmakers A; Corveleyn A; Devriendt K; van Tienoven TP; Allegaert K; Van Dyck M; van den Heuvel L; Kuypers D; Claes K; Mekahli D; Levtchenko E
    Nephrol Dial Transplant; 2015 May; 30(5):835-42. PubMed ID: 25500806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
    Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
    Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes.
    Gatalica Z; Lilleberg SL; Monzon FA; Koul MS; Bridge JA; Knezetic J; Legendre B; Sharma P; McCue PA
    Hum Pathol; 2011 Dec; 42(12):1979-88. PubMed ID: 21733559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations.
    Oram RA; Edghill EL; Blackman J; Taylor MJ; Kay T; Flanagan SE; Ismail-Pratt I; Creighton SM; Ellard S; Hattersley AT; Bingham C
    Am J Obstet Gynecol; 2010 Oct; 203(4):364.e1-5. PubMed ID: 20633866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of MODY5-like manifestations without mutations or deletions in coding and minimal promoter regions of the HNF1B gene.
    Kuwabara-Ohmura Y; Iizuka K; Liu Y; Takao K; Nonomura K; Kato T; Mizuno M; Hosomichi K; Tajima A; Miyazaki T; Horikawa Y; Yabe D
    Endocr J; 2020 Sep; 67(9):981-988. PubMed ID: 32461507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
    Shen H; Fridley BL; Song H; Lawrenson K; Cunningham JM; Ramus SJ; Cicek MS; Tyrer J; Stram D; Larson MC; Köbel M; ; Ziogas A; Zheng W; Yang HP; Wu AH; Wozniak EL; Woo YL; Winterhoff B; Wik E; Whittemore AS; Wentzensen N; Weber RP; Vitonis AF; Vincent D; Vierkant RA; Vergote I; Van Den Berg D; Van Altena AM; Tworoger SS; Thompson PJ; Tessier DC; Terry KL; Teo SH; Templeman C; Stram DO; Southey MC; Sieh W; Siddiqui N; Shvetsov YB; Shu XO; Shridhar V; Wang-Gohrke S; Severi G; Schwaab I; Salvesen HB; Rzepecka IK; Runnebaum IB; Rossing MA; Rodriguez-Rodriguez L; Risch HA; Renner SP; Poole EM; Pike MC; Phelan CM; Pelttari LM; Pejovic T; Paul J; Orlow I; Omar SZ; Olson SH; Odunsi K; Nickels S; Nevanlinna H; Ness RB; Narod SA; Nakanishi T; Moysich KB; Monteiro AN; Moes-Sosnowska J; Modugno F; Menon U; McLaughlin JR; McGuire V; Matsuo K; Adenan NA; Massuger LF; Lurie G; Lundvall L; Lubiński J; Lissowska J; Levine DA; Leminen A; Lee AW; Le ND; Lambrechts S; Lambrechts D; Kupryjanczyk J; Krakstad C; Konecny GE; Kjaer SK; Kiemeney LA; Kelemen LE; Keeney GL; Karlan BY; Karevan R; Kalli KR; Kajiyama H; Ji BT; Jensen A; Jakubowska A; Iversen E; Hosono S; Høgdall CK; Høgdall E; Hoatlin M; Hillemanns P; Heitz F; Hein R; Harter P; Halle MK; Hall P; Gronwald J; Gore M; Goodman MT; Giles GG; Gentry-Maharaj A; Garcia-Closas M; Flanagan JM; Fasching PA; Ekici AB; Edwards R; Eccles D; Easton DF; Dürst M; du Bois A; Dörk T; Doherty JA; Despierre E; Dansonka-Mieszkowska A; Cybulski C; Cramer DW; Cook LS; Chen X; Charbonneau B; Chang-Claude J; Campbell I; Butzow R; Bunker CH; Brueggmann D; Brown R; Brooks-Wilson A; Brinton LA; Bogdanova N; Block MS; Benjamin E; Beesley J; Beckmann MW; Bandera EV; Baglietto L; Bacot F; Armasu SM; Antonenkova N; Anton-Culver H; Aben KK; Liang D; Wu X; Lu K; Hildebrandt MA; ; ; Schildkraut JM; Sellers TA; Huntsman D; Berchuck A; Chenevix-Trench G; Gayther SA; Pharoah PD; Laird PW; Goode EL; Pearce CL
    Nat Commun; 2013; 4():1628. PubMed ID: 23535649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
    da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
    J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
    Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
    J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.